| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.047 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |